Theresa Wingrove, SVP OF REGULATORY AFFAIRS at ImmunoGen, Inc. (IMGN), sold 342,432 shares at $28.95 ($9.7M) on 2023-11-30, disclosed to the SEC on 2023-12-01.
Scheduled sale ($9.7M) by SVP OF REGULATORY AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.66 | 6,792 | $113K | 1.2% |
| 2 | $16.66 | 6,792 | $113K | 1.2% |
| 3 | $28.95 | 164,424 | $4.8M | 48.8% |
| 4 | $28.95 | 164,424 | $4.8M | 48.8% |
| Total | $28.46 avg | 342,432 | $9.7M | 100% |
| Filing → |
| IMGN | SELL | 2023-12-19 | $3.5M | — | Filing → |
| IMGN | SELL | 2023-11-17 | $5.3M | — | Filing → |
| IMGN | SELL | 2023-11-08 | $650K | — | Filing → |